z-logo
open-access-imgOpen Access
Rucaparib Improves PFS in BRCA-Mutant Recurrent Ovarian Cancer
Author(s) -
Mark L. Fuerst
Publication year - 2017
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000527174.57408.58
Subject(s) - ovarian cancer , brca mutation , parp inhibitor , medicine , oncology , cancer , cancer research , chemotherapy , poly adp ribose polymerase , biology , genetics , dna , polymerase

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom